| Anti-NKG2A mAb is a checkpoint inhibitor that promotes anti-tumor immunity by unleashing both T and NK cells P André, C Denis, C Soulas, C Bourbon-Caillet, J Lopez, T Arnoux, ... Cell 175 (7), 1731-1743. e13, 2018 | 1134 | 2018 |
| Retropharyngeal infections in children. Treatment strategies and outcomes C Hoffmann, S Pierrot, P Contencin, MP Morisseau-Durand, Y Manach, ... International Journal of Pediatric Otorhinolaryngology 75 (9), 1099-1103, 2011 | 106 | 2011 |
| Selective STING stimulation in dendritic cells primes antitumor T cell responses B Jneid, A Bochnakian, C Hoffmann, F Delisle, E Djacoto, P Sirven, ... Science Immunology 8 (79), eabn6612, 2023 | 78 | 2023 |
| Early glottic cancer involving the anterior commissure treated by transoral laser cordectomy C Hoffmann, N Cornu, S Hans, B Sadoughi, C Badoual, D Brasnu The Laryngoscope 126 (8), 1817-1822, 2016 | 75 | 2016 |
| Prognostic value of intratumoral Fusobacterium nucleatum and association with immune-related gene expression in oral squamous cell carcinoma patients C Neuzillet, M Marchais, S Vacher, M Hilmi, A Schnitzler, D Meseure, ... Scientific Reports 11 (1), 1-13, 2021 | 73 | 2021 |
| Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival C Dubot, V Bernard, MP Sablin, S Vacher, W Chemlali, A Schnitzler, ... European Journal of Cancer 91, 47-55, 2018 | 70 | 2018 |
| Plasmacytoid pre-dendritic cells (pDC): from molecular pathways to function and disease association S Alculumbre, S Raieli, C Hoffmann, R Chelbi, FX Danlos, V Soumelis Seminars in cell & developmental biology 86, 24-35, 2019 | 69 | 2019 |
| Functional results of Vibrant Soundbridge middle ear implants in conductive and mixed hearing losses D Bernardeschi, C Hoffman, T Benchaa, S Labassi, M Beliaeff, O Sterkers, ... Audiology and Neurotology 16 (6), 381-387, 2011 | 64 | 2011 |
| Immune gene expression in head and neck squamous cell carcinoma patients C Lecerf, M Kamal, S Vacher, W Chemlali, A Schnitzler, C Morel, C Dubot, ... European Journal of Cancer 121, 210-223, 2019 | 62 | 2019 |
| Phase I dose-escalation study of NBTXR3 activated by intensity-modulated radiation therapy in elderly patients with locally advanced squamous cell carcinoma of the oral cavity … C Hoffmann, V Calugaru, E Borcoman, V Moreno, E Calvo, X Liem, ... European Journal of Cancer 146, 135-144, 2021 | 54 | 2021 |
| Identifying outcome predictors of transoral laser cordectomy for early glottic cancer C Hoffmann, S Hans, B Sadoughi, D Brasnu Head & Neck 38 (S1), E406-E411, 2016 | 50 | 2016 |
| Biomarkers of cetuximab resistance in patients with head and neck squamous cell carcinoma O Leblanc, S Vacher, C Lecerf, E Jeannot, J Klijanienko, F Berger, ... Cancer Biology & Medicine 17 (1), 208, 2020 | 38 | 2020 |
| Transoral robotic-assisted free flap reconstruction after radiation therapy in hypopharyngeal carcinoma: report of two cases S Hans, T Jouffroy, D Veivers, C Hoffman, A Girod, C Badoual, ... European Archives of Oto-Rhino-Laryngology 270 (8), 2359-2364, 2013 | 34 | 2013 |
| Acellular fish skin matrix on thin-skin graft donor sites: a preliminary study N Badois, P Bauër, M Cheron, C Hoffmann, M Nicodeme, O Choussy, ... Journal of Wound Care 28 (9), 624-628, 2019 | 32 | 2019 |
| Meta-analysis of human cancer single cell RNA-seq datasets using the IMMUcan database. J Camps, F Noël, R Liechti, L Massenet-Regad, S Rigade, L Götz, ... Cancer Research, CAN-22, 2022 | 31 | 2022 |
| Unmet Needs and Perspectives in Oral Cancer Prevention J Bouaoud, P Bossi, M Elkabets, S Schmitz, LC van Kempen, P Martinez, ... Cancers 14 (7), 1815, 2022 | 27 | 2022 |
| Prognostic value of tumor mutational burden in patients with oral cavity squamous cell carcinoma treated with upfront surgery A Moreira, A Poulet, J Masliah-Planchon, C Lecerf, S Vacher, LL Chérif, ... ESMO Open 6 (4), 100178, 2021 | 26 | 2021 |
| PD-L1 and ICOSL discriminate human Secretory and Helper dendritic cells in cancer, allergy and autoimmunity C Hoffmann, F Noel, M Grandclaudon, L Massenet-Regad, P Michea, ... Nature Communications 13 (1), 1-20, 2022 | 23 | 2022 |
| Identification of new candidate therapeutic target genes in head and neck squamous cell carcinomas MP Sablin, C Dubot, J Klijanienko, S Vacher, L Ouafi, W Chemlali, M Caly, ... Oncotarget 7 (30), 47418, 2016 | 23 | 2016 |
| Exploratory window‐of‐opportunity trial to investigate the tumor pharmacokinetics/pharmacodynamics of the IAP antagonist Debio 1143 in patients with head and neck cancer C Gomez‐Roca, C Even, C Le Tourneau, N Basté, JP Delord, J Sarini, ... Clinical and translational science 15 (1), 55-62, 2022 | 18 | 2022 |